# LEVONORGESTREL AND ETHINYL ESTRADIOL
> **ANDA212298** · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS · Approved 2023-02-13
## Drug
- **FDA Application Number:** ANDA212298
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LEVONORGESTREL AND ETHINYL ESTRADIOL
- **Generic name:** LEVONORGETSREL AND ETHINYL ESTRADIOL
- **Active ingredients:** ETHINYL ESTRADIOL; LEVONORGESTREL
- **Dosage form:** TABLET
- **Route:** ORAL-28
- **Marketing status:** Prescription
- **Sponsor:** HETERO LABS
- **Manufacturer:** Camber Pharmaceuticals, Inc.
- **First approval:** 2023-02-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212298)
---
*MORVS · CC0 1.0*